Cytogenix Inc. (CYGX) news stock charts
Cytogenix Inc. (CYGX/CYGX.OB) Investment Summary:
CytoGenix, Inc., a biopharmaceutical company, focuses on the development and commercialization of its technology for identifying and silencing disease causing genes and expressing proteins for applications, such as vaccines and isolating novel nucleic acid-based anti-microbial compounds. Its technologies include gene silencing techniques applicable to genes from pathogenic organisms or selected genes from a host to prevent the expression of harmful proteins, thereby preventing, or ameliorating disease; a cell free process to produce DNA for use in its own products, as well as for sale to other biopharmaceutical or life science companies; and a methodology to isolate and characterize DNA-base...www.cytogenix.com
3 Employees
Founded in 1995
CYTOGENIX INC (CYGX:OTC)
LAST $0.0048 USD
CHANGE TODAY 0.00 0.00%
VOLUME 1.0K
As of 8:10 PM 03/18/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of CYTOGENIX INC (CYGX)
|
OPEN
$0.0048
|
PREVIOUS CLOSE
$0.0048
|
|
|
DAY HIGH
$0.0048
|
DAY LOW
$0.0048
|
|
|
52 WEEK HIGH
05/7/09 - $0.04
|
52 WEEK LOW
02/12/10 - $0.0031
|
|
|
MARKET CAP
813.1K
|
AVERAGE VOLUME 10 D
29.7K
|
|
|
EPS TTM
$-0.02
|
SHARES OUTSTANDING
169.4M
|
|
|
CYGX Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for CYTOGENIX INC (CYGX)
Cytogenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2009
05/21/2009
Cytogenix Inc. reported earnings results for the first quarter ended March 31, 2009. The company reported a net loss of $203,193. In contrast, the company posted a net loss of $883,255 for the same quarter in the previous year.
Cytogenix Inc. has Changed its Ticker to CYGX from CYGX.E
05/20/2009
Cytogenix Inc. changed its OTCBB stock ticker symbol to CYGX from CYGX.E.
Cytogenix Deleted From OTCBB
05/19/2009
Cytogenix Inc.'s common stock has been deleted from OTC Bulletin Board effective May 20, 2009 on account of its failure to comply with NASD 6530. The company has been added to NBB.
Cytogenix Inc. financial resources
CYGX Competitors
| Company | Last | Change | |
| No competitor information is available for CYGX. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | CYGX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 19.8x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 15.9x |
|
|
CYGX |
||
|
CYGX transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Cytogenix Inc.
Would you like to leave a comment about Cytogenix Inc. CYGX/CYGX.OB
Find out what social network information about Cytogenix Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Cytogenix Inc.'s Stock there is more great penny stock and market information at Realpennies